Pharma jousts statistically for an ankylosing spondylitis edgeJuly 1, 2016SpondyloarthropathiesAnkylosing spondylitis
NSAID plus TNFi linked to less ankylosing spondylitis progressionJune 28, 2016SpondyloarthropathiesAnkylosing spondylitis
NSAID plus TNFi linked to less ankylosing spondylitis progressionJune 28, 2016SpondyloarthropathiesAnkylosing spondylitis
VIDEO: Updated axial SpA recommendations include IL-17 inhibitorsJune 12, 2016SpondyloarthropathiesAnkylosing spondylitis
Secukinumab may slow structural ankylosing spondylitis progressionJune 9, 2016Ankylosing spondylitisSpondyloarthropathies
High spondyloarthritis risk found in first-degree relatives of ankylosing spondylitis patientsJune 2, 2016SpondyloarthropathiesAnkylosing spondylitis
Doctors ask Congress to stop Part B drug payment testMay 17, 2016SpondyloarthropathiesAnkylosing spondylitisPsoriatic ArthritisRheumatoid ArthritisBusiness of Medicine
PIANO study provides insight on safety of biologics in pregnancyMay 11, 2016Rheumatoid ArthritisSpondyloarthropathiesAnkylosing spondylitisPsoriatic Arthritis
Remicade to infliximab biosimilar switches fare well in real-life practiceMay 3, 2016SpondyloarthropathiesRheumatoid ArthritisAnkylosing spondylitisPsoriatic Arthritis
Secukinumab improves patient-reported outcomes in ankylosing spondylitisApril 27, 2016Ankylosing spondylitisSpondyloarthropathies
After Inflectra’s approval, challenges remain for biosimilarsApril 26, 2016Rheumatoid ArthritisAnkylosing spondylitisPsoriatic ArthritisLupus & Connective Tissue DiseasesPediatricsSpondyloarthropathies
Inflectra becomes first FDA-approved biosimilar for inflammatory diseasesApril 5, 2016Rheumatoid ArthritisAnkylosing spondylitisPsoriatic ArthritisSpondyloarthropathies
Genetics, smoking, and inflammation on MRI predict progression in axial SpAMarch 29, 2016SpondyloarthropathiesAnkylosing spondylitis
Pushback on Part B drug payment proposal already beginningMarch 22, 2016Rheumatoid ArthritisAnkylosing spondylitisPsoriatic ArthritisLupus & Connective Tissue DiseasesPediatricsSpondyloarthropathiesBusiness of Medicine
Home infusion policies called out in ACR position statementMarch 22, 2016Rheumatoid ArthritisLupus & Connective Tissue DiseasesPediatricsSpondyloarthropathiesAnkylosing spondylitisPsoriatic Arthritis
